Home Biosimilar Antibodies Others Others Lacnotuzumab (Anti-CSF1 / M-CSF)
For research use only. Not for use in humans.

Lacnotuzumab (Anti-CSF1 / M-CSF)

Synonyms: MCS110; Anti-Human B7-H3

Lacnotuzumab (Anti-CSF1 / M-CSF) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1, that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis. MW: 150 KD.

Lacnotuzumab (Anti-CSF1 / M-CSF)

Click to purchase the isotype control of Lacnotuzumab (Anti-CSF1 / M-CSF)

Quality Control

Batch: A253401 Purity: 99% Protein concentration: 6.25mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Lacnotuzumab (Anti-CSF1 / M-CSF) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1, that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis. MW: 150 KD.

Product Details

CAS No. 1831128-32-5
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.